Antibody Drug Conjugates Market Size, Share, Analysis, Industry Report and Forecast 2021-2027
The global antibody drug conjugates market is anticipated to grow at a considerable CAGR during the forecast period. The antibody-drug conjugates are a significant group of highly potent bio-pharmaceutical drugs that are designed as a targeted treatment for the healing of cancer patients.
The increasing prevalence of cancer is pushing the demand for antibody drug conjugates market. For instance, in 2017, in the US, 1,701,315 new cases were reported of cancer, and 599,099 people died due to the same. Every 100,000 people, 438 new cancer cases were reported and 153 people died due to that. In 2020, it was estimated that 1,806,590 new cases of cancer were diagnosed in the US and there were 606,520 mortalities due to the disease.
To Request a Sample of our Report on Antibody Drug Conjugates Market: https://www.omrglobal.com/request-sample/antibody-drug-conjugates-market
Moreover, the availability of a large product pipeline and the
increasing trend of cost-effective and quality cancer treatment are other
factors that are driving the global antibody drug conjugates industry.
Market Coverage
·
The
market number available for – 2020-2027
·
Base
year- 2020
·
Forecast
period- 2021-2027
Segment Covered-
·
By
Application
·
By
Technology
Regions Covered-
·
North
America
·
Europe
·
Asia-Pacific
·
Rest of
the World
Competitive Landscape- AbbVie Inc., Astellas Pharma Inc., Bayer AG,
Celldex Therapeutics, Inc., Creative Biolabs, Inc., ImmunoGen, Inc.,
Lonza Group, Pfizer Inc., Seattle Genetics, Inc.
Key Questions Addressed by the Report
·
What is
the market growth rate?
·
Which
segment and region dominate the market in the base year?
·
Which
segment and region will project the fastest growth in the market?
·
How
COVID-19 impacted the market?
o Deviation from the
pre-COVID-19 forecast
o Most affected region
and segment
·
Who is the
leader in the market?
·
How are
players addressing challenges to sustain growth?
·
Where
is the investment opportunity?
A full
Report of Antibody Drug Conjugates Market is Available at: https://www.omrglobal.com/industry-reports/antibody-drug-conjugates-market
·
Blood
Cancer
·
Breast
Cancer
·
Ovarian
Cancer
·
Lung
Cancer
·
Others
By Technology
·
Cleavable
Linker
·
Non-cleavable
Linker
Global
Antibody Drug Conjugates Market Report Segment by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
Rest of APAC
Rest of The World
·
Latin
America
·
Middle
East & Africa
Company
Profiles
·
AbbVie
Inc.
·
Astellas
Pharma Inc.
·
Bayer
AG
·
Celldex
Therapeutics, Inc.
·
Creative
Biolabs, Inc.
·
Genentech,
Inc.
·
Heidelberg
Pharma AG
·
ImmunoGen,
Inc.
·
Immunomedics,
Inc.
·
Lonza
Group
·
Mersana
Therapeutics, Inc.
·
Oxford
BioTherapeutics Ltd.
·
Pfizer
Inc.
·
Progenics
Pharmaceuticals Inc.
·
Seattle
Genetics, Inc.
·
Sorrento
Therapeutics, Inc.
·
Synthon
Holding B.V.
·
Takeda
Pharmaceutical Co. Ltd.
Reasons for Buying from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/antibody-drug-conjugates-market
About Orion
Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment